Publication | Closed Access

Insight into potent TLR2 inhibitors for the treatment of disease caused by Mycoplasma pneumoniae based on machine learning approaches

Computational MedicineMachine Learning ApproachesHealth SciencesTranslational BioinformaticsMedicineMycoplasma PneumoniaeImmunologyRational Drug DesignTarget PredictionPotent Tlr2 InhibitorsImmunotherapyMolecular DiagnosticsClinical MicrobiologyNovel TherapyDrug DiscoveryDrug Resistance